Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Pediatric Trials

Philadelphia, Pennsylvania

CNS trials open to children and teens in Philadelphia, PA

13 CNS studies open to children and teens are recruiting participants at sites in Philadelphia as of November 18, 2026, according to ClinicalTrials.gov. CNS Pediatric Trials can help you understand your options and connect with a study team.

Call (888) 927-9530
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Philadelphia at a glance

  • 13 studies are recruiting at a site in Philadelphia.
  • By phase: Phase 1 (1), Phase 1/2 (1), Phase 3 (5), Phase 4 (2), No phase (4). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (7), university, hospital or other (6).
  • By research area: Migraine (6), Depression (3), ADHD (2), Epilepsy (2).
  • Most recent update to one of these records: November 2, 2026.

ADHD studies recruiting in Philadelphia

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. AWARE: Management of ADHD in Autism Spectrum Disorder

    • Phase 4
    • Ages 4 to 17
    • All sexes
    Sponsor
    Daniel Coury
    Study site
    Children's Hospital of Philadelphia
    Registry record
    NCT05916339 · updated
  2. Treating Young Children With Attention Deficit Hyperactivity Disorder

    • Phase 4
    • Ages 3 to 5
    • All sexes
    Sponsor
    Children's Hospital Medical Center, Cincinnati
    Study site
    Children's Hospital of Philadelphia
    Registry record
    NCT07300956 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Philadelphia, PA on ClinicalTrials.gov.

Depression studies recruiting in Philadelphia

  1. Removing Surrogates Uncertainty to Reduce Fear and Anxiety After Cardiac Events - Kids

    • No phase
    • From 0 days, up to 17 years
    • All sexes
    Sponsor
    Children's Hospital of Philadelphia
    Study site
    Children's Hospital of Philadelphia
    Registry record
    NCT07707037 · updated
  2. Get ActivE Study for At-risk Youth

    • No phase
    • Ages 12 to 18
    • All sexes
    Sponsor
    University of Pittsburgh
    Study site
    Children's Hospital of Philadelphia
    Registry record
    NCT06829953 · updated
  3. Transdiagnostic Sleep and Circadian Intervention + Bright Light in Adolescents With Elevated Depression (TranS-C+BL)

    • No phase
    • Ages 12 to 18
    • All sexes
    Sponsor
    University of Pittsburgh
    Study site
    Childrens Hospital of Philadelphia
    Registry record
    NCT06963463 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Philadelphia, PA on ClinicalTrials.gov.

Epilepsy studies recruiting in Philadelphia

  1. ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

    • Phase 1/2
    • Ages 2 to 12
    • All sexes
    Sponsor
    Ionis Pharmaceuticals, Inc.
    Study site
    The Children's Hospital of Philadelphia (CHOP)
    Registry record
    NCT07531745 · updated
  2. A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

    • Phase 3
    • From 1 day, up to 18 years
    • All sexes
    Sponsor
    Praxis Precision Medicines
    Study site
    Praxis Research Site
    Registry record
    NCT07019922 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Philadelphia, PA on ClinicalTrials.gov.

Migraine studies recruiting in Philadelphia

  1. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Study site
    Clario
    Registry record
    NCT04649242 · updated
  2. A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    AbbVie
    Study site
    The Children's Hospital of Philadelphia /ID# 270842
    Registry record
    NCT06810505 · updated
  3. A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Study site
    Children's Hospital of Philadelphia - Main /ID# 258071
    Registry record
    NCT05711394 · updated
  4. A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

    • Phase 1
    • Ages 6 to 11
    • All sexes
    Sponsor
    Pfizer
    Study site
    Children's Hospital of Philadelphia
    Registry record
    NCT06995729 · updated
  5. Responding With Evidence and Access for Childhood Headaches

    • No phase
    • Ages 10 to 17
    • All sexes
    Sponsor
    Children's Hospital Medical Center, Cincinnati
    Study site
    Children's Hospital of Philadelphia
    Registry record
    NCT05889624 · updated
  6. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Study site
    Children's Hospital of Philadelphia - Main /ID# 232487
    Registry record
    NCT05125302 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Philadelphia, PA on ClinicalTrials.gov.

Ask about studies near Philadelphia

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Pennsylvania

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.

CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9530

or send a short form

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?

Call